JAC Advance Access originally published online on May 12, 2006
Journal of Antimicrobial Chemotherapy 2006 58(1):159-167; doi:10.1093/jac/dkl147
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (19972002)

1 ESAC Management Team, Laboratory of Medical Microbiology, University of Antwerp, Universiteitsplein 1 B-2610 Antwerp, Belgium 2 Heymans Institute of Pharmacology, Ghent University De Pintelaan, 185, B-9000 Gent, Belgium 3 Department of Nursing Research, University of Antwerp Universiteitsplein 1, B-2610 Antwerp, Belgium 4 Department of Intensive Care, Ghent University Hospital De Pintelaan, 185, B-9000 Gent, Belgium 5 Leiden University Medical Center, Postbus 9600 2333 RC Leiden, The Netherlands
Received 22 December 2005; returned 3 February 2006; revised 19 March 2006; accepted 23 March 2006
*Correspondence address. Laboratory of Medical Microbiology, University of Antwerp, Universiteitsplein 1, 2610 Antwerpen-Wilrijk, Belgium. E-mail: Herman.Goossens{at}uza.be
Objectives: To collect reliable, comparable and publicly available data on hospital use of antibiotics in Europe aggregated at the national level (19972002).
Methods: Consumption data of systemic antibiotics in Anatomical Therapeutic Chemical (ATC) class J01 were collected and expressed in defined daily doses (DDD) per 1000 inhabitants per day. Valid data for 2002 were available for 15 countries, and 6 year trends for 10 countries. Comparison with ambulatory care (AC) consumption data was possible in 14 countries.
Results: In 2002, median national hospital antibiotic consumption in Europe was 2.1 DDD/1000 inhabitants/day in Europe, ranging from 3.9 in Finland and France to 1.3 in Norway and Sweden. Hospital care (HC) consumption as a proportion of total antibiotic consumption ranged from 17.8% to 6.4%. The consumption of hospital-specific antibiotics ranged from 0.43 DDD/1000 inhabitants/day in Greece and 0.08 in Sweden. Six-year trends in consumption were stable, except for rising co-amoxiclav exposure and more rapid market penetration of new antibiotics (e.g. levofloxacin) in some countries. There was a strong, positive correlation between the extent of antibiotic use in AC and in HC (Spearman coefficient 0.745; P = 0.002), both for overall use and for use of five main classes (not macrolides and others). In contrast to AC consumption no substantial seasonal variation in consumption was observed.
Conclusions: It was cumbersome but feasible to collect ecological data on hospital antibiotic consumption in a set of 15 European countries on a retrospective basis, illustrating substantial cross-national variations in the extent and distribution of exposure to antibiotics in hospital care.
Keywords: antibacterial agents , data collection , hospitals , drug utilization , Europe , factual databases , microbial drug resistance
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. P. Kuster, C. Ruef, A. K. Bollinger, B. Ledergerber, A. Hintermann, C. Deplazes, L. Neuber, and R. Weber Correlation between case mix index and antibiotic use in hospitals J. Antimicrob. Chemother., October 1, 2008; 62(4): 837 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miliani, F. L'Heriteau, S. Alfandari, I. Arnaud, Y. Costa, E. Deliere, A. Carbonne, P. Astagneau, and on behalf on the Antimicrobial Surveillance Networ Specific control measures for antibiotic prescription are related to lower consumption in hospitals: results from a French multicentre pilot study J. Antimicrob. Chemother., October 1, 2008; 62(4): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shalit, M. Low, E. Levy, M. Chowers, O. Zimhony, K. Riesenberg, J. Bishara, and R. Raz Antibiotic use in 26 departments of internal medicine in 6 general hospitals in Israel: variability and contributing factors J. Antimicrob. Chemother., July 1, 2008; 62(1): 196 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vaccheri, M. C. Silvani, L. Bersaglia, D. Motola, P. Strahinja, A. Vargiu, E. Poluzzi, and N. Montanaro A 3 year survey on the use of antibacterial agents in five Italian hospitals J. Antimicrob. Chemother., April 1, 2008; 61(4): 953 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Freundlich, R. W. Thomsen, L. Pedersen, H. West, and H. C. Schonheyder Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study J. Antimicrob. Chemother., November 1, 2007; 60(5): 1115 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanerva, J. Ollgren, O. Lyytikainen, and on behalf of the Finnish Prevalence Survey Study G Antimicrobial use in Finnish acute care hospitals: data from national prevalence survey, 2005 J. Antimicrob. Chemother., August 1, 2007; 60(2): 440 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vidal, A. Gafter-Gvili, S. Borok, A. Fraser, L. Leibovici, and M. Paul Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials J. Antimicrob. Chemother., August 1, 2007; 60(2): 247 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Torfoss, E. A. Hoiby, J. M. Tangen, H. Holte, K. Bo, P. Meyer, K. Grottum, K. Weyde, G. F. Lauritzsen, B. Sandstad, et al. Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial J. Antimicrob. Chemother., April 1, 2007; 59(4): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Berrington Hospital antibiotic prescribing data require careful local interpretation J. Antimicrob. Chemother., January 1, 2007; 59(1): 162 - 163. [Full Text] [PDF] |
||||
![]() |
W. V. Kern, M. Steib-Bauert, and K. d. With Comment on: Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997--2002) J. Antimicrob. Chemother., October 1, 2006; 58(4): 900 - 901. [Full Text] [PDF] |
||||
![]() |
H. Goossens Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002)--author response J. Antimicrob. Chemother., October 1, 2006; 58(4): 901 - 902. [Full Text] [PDF] |
||||
![]() |
F. M. MacKenzie, D. L. Monnet, I. M. Gould, and on behalf of the ARPAC Steering Group Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals J. Antimicrob. Chemother., September 1, 2006; 58(3): 657 - 660. [Abstract] [Full Text] [PDF] |
||||
